Home/Filings/4/0001493152-18-010762
4//SEC Filing

HESTERBERG LYNDAL K. 4

Accession 0001493152-18-010762

CIK 0001642380other

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 9:38 PM ET

Size

6.9 KB

Accession

0001493152-18-010762

Insider Transaction Report

Form 4
Period: 2018-07-26
HESTERBERG LYNDAL K.
Sr VP, Research & Development
Transactions
  • Purchase

    Common stock purchase warrants

    2018-07-26+874874 total
    Exercise: $3.00From: 2019-02-01Exp: 2024-02-01Common stock (874 underlying)
  • Purchase

    Common stock, no par value

    2018-07-26+874874 total
Footnotes (1)
  • [F1]The shares of common stock and the common stock purchase warrants reported in this Form were purchased in "units," with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86.

Documents

1 file

Issuer

OncoCyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001689836

Filing Metadata

Form type
4
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:38 PM ET
Size
6.9 KB